GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SWS Hemodialysis Care Co Ltd (SHSE:688410) » Definitions » Piotroski F-Score

SWS Hemodialysis Care Co (SHSE:688410) Piotroski F-Score : 6 (As of Apr. 22, 2025)


View and export this data going back to 2022. Start your Free Trial

What is SWS Hemodialysis Care Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

SWS Hemodialysis Care Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for SWS Hemodialysis Care Co's Piotroski F-Score or its related term are showing as below:

SHSE:688410' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 6   Max: 8
Current: 6

During the past 10 years, the highest Piotroski F-Score of SWS Hemodialysis Care Co was 8. The lowest was 2. And the median was 6.


SWS Hemodialysis Care Co Piotroski F-Score Historical Data

The historical data trend for SWS Hemodialysis Care Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SWS Hemodialysis Care Co Piotroski F-Score Chart

SWS Hemodialysis Care Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.00 3.00 8.00 7.00 6.00

SWS Hemodialysis Care Co Quarterly Data
Mar18 Jun18 Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 6.00 5.00 5.00 6.00

Competitive Comparison of SWS Hemodialysis Care Co's Piotroski F-Score

For the Medical Instruments & Supplies subindustry, SWS Hemodialysis Care Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SWS Hemodialysis Care Co's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SWS Hemodialysis Care Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where SWS Hemodialysis Care Co's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Net Income was 12.881 + 34.232 + 11.524 + 16.186 = ¥74.8 Mil.
Cash Flow from Operations was 167.28 + 0.327 + 27.108 + 37.305 = ¥232.0 Mil.
Revenue was 114.48 + 162.082 + 115.448 + 140.443 = ¥532.5 Mil.
Gross Profit was 53.831 + 76.307 + 54.186 + 68.204 = ¥252.5 Mil.
Average Total Assets from the begining of this year (Sep23)
to the end of this year (Sep24) was
(1931.789 + 1935.769 + 1903.307 + 1948.109 + 1928.521) / 5 = ¥1929.499 Mil.
Total Assets at the begining of this year (Sep23) was ¥1,931.8 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1.0 Mil.
Total Current Assets was ¥1,652.0 Mil.
Total Current Liabilities was ¥137.4 Mil.
Net Income was 25.045 + 74.586 + 59.654 + 47.377 = ¥206.7 Mil.

Revenue was 122.747 + 193.032 + 201.647 + 180.953 = ¥698.4 Mil.
Gross Profit was 58.43 + 109.717 + 109.759 + 99.819 = ¥377.7 Mil.
Average Total Assets from the begining of last year (Sep22)
to the end of last year (Sep23) was
(625.66 + 1925.723 + 2030.521 + 1988.502 + 1931.789) / 5 = ¥1700.439 Mil.
Total Assets at the begining of last year (Sep22) was ¥625.7 Mil.
Long-Term Debt & Capital Lease Obligation was ¥5.2 Mil.
Total Current Assets was ¥1,763.5 Mil.
Total Current Liabilities was ¥157.1 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

SWS Hemodialysis Care Co's current Net Income (TTM) was 74.8. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

SWS Hemodialysis Care Co's current Cash Flow from Operations (TTM) was 232.0. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep23)
=74.823/1931.789
=0.03873249

ROA (Last Year)=Net Income/Total Assets (Sep22)
=206.662/625.66
=0.33031039

SWS Hemodialysis Care Co's return on assets of this year was 0.03873249. SWS Hemodialysis Care Co's return on assets of last year was 0.33031039. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

SWS Hemodialysis Care Co's current Net Income (TTM) was 74.8. SWS Hemodialysis Care Co's current Cash Flow from Operations (TTM) was 232.0. ==> 232.0 > 74.8 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=0.988/1929.499
=0.00051205

Gearing (Last Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=5.228/1700.439
=0.0030745

SWS Hemodialysis Care Co's gearing of this year was 0.00051205. SWS Hemodialysis Care Co's gearing of last year was 0.0030745. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep24)=Total Current Assets/Total Current Liabilities
=1652.039/137.446
=12.0195495

Current Ratio (Last Year: Sep23)=Total Current Assets/Total Current Liabilities
=1763.46/157.127
=11.2231507

SWS Hemodialysis Care Co's current ratio of this year was 12.0195495. SWS Hemodialysis Care Co's current ratio of last year was 11.2231507. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

SWS Hemodialysis Care Co's number of shares in issue this year was 320.12. SWS Hemodialysis Care Co's number of shares in issue last year was 321.373. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=252.528/532.453
=0.47427285

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=377.725/698.379
=0.54085962

SWS Hemodialysis Care Co's gross margin of this year was 0.47427285. SWS Hemodialysis Care Co's gross margin of last year was 0.54085962. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep23)
=532.453/1931.789
=0.27562689

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep22)
=698.379/625.66
=1.11622766

SWS Hemodialysis Care Co's asset turnover of this year was 0.27562689. SWS Hemodialysis Care Co's asset turnover of last year was 1.11622766. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+1+0+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

SWS Hemodialysis Care Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

SWS Hemodialysis Care Co  (SHSE:688410) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


SWS Hemodialysis Care Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of SWS Hemodialysis Care Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


SWS Hemodialysis Care Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Ciji Road, Liangjiang New District, Chongqing, CHN, 401123
SWS Hemodialysis Care Co Ltd along with its subsidiaries is engaged in the field of blood purification. Its focused on patients welfare and ensuring the delivery of safe and effective products and services. The group operates through four segments: Blood Purification Equipment, Blood Purification Consumables, advanced Hemodialysis Management System, and Chain Dialysis centers. The organization is delivering medical solutions for patients with chronic kidney disease (CKD). Its products include Blood Purification Equipment Dialysis, Disposables Dialysis Center, Intelligent Management System, and Chain Dialysis centers. SWS is committed to enhancing patient wellness by prioritizing care through advanced integrated blood purification technologies.
Executives
Gao Guang Yong Directors, senior managers, core technical personn

SWS Hemodialysis Care Co Headlines

No Headlines